本頁面由Tiger Trade Technology Pte. Ltd.提供服務

大自然藥業

4.46
-0.3500-7.28%
盤後4.460.00000.00%19:16 EDT
成交量:6.01萬
成交額:27.13萬
市值:2,240.88萬
市盈率:-1.29
高:4.74
開:4.60
低:4.39
收:4.81
52周最高:17.96
52周最低:2.00
股本:502.44萬
流通股本:55.99萬
量比:0.75
換手率:10.74%
股息:- -
股息率:- -
每股收益(TTM):-3.4482
每股收益(LYR):-8.0550
淨資產收益率:-3.50%
總資產收益率:-1.72%
市淨率:0.40
市盈率(LYR):-0.55

資料載入中...

2026/09/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/01/29

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/06/06

SEC問詢函

Form CORRESP - Correspondence
2024/05/15

SEC問詢函

Form CORRESP - Correspondence
2024/05/14

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/04/24

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/01/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/10

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/17

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/17

SEC問詢函

CORRESP [Cover] - Correspondence